[1]阎明, 孟繁立, 肝硬化肝肾综合征的治疗[J], 中华肝脏病杂志, 2005, 13 (6) :458.
|
[2]Salerno F, Gerbes A, Gines P, et al.Diagnosis, preventionand treatment of hepatorenal syndrome in cirrhosis[J].Gut, 2007, 56 (9) :1310-1318
|
[3]梁汝忠, 梁月连, 杨彬.肝肾综合征并发电解质和酸碱失衡的临床研究[J]、实用医技杂志, 2005, 12 (4) :915-917
|
[4]韦志明.肝肾综合征发病机制及药物治疗进展[J].华夏医学, 2008, 21 (4) :842-844.
|
[5]Wong F, Blendis L.New challenge of hepatorenalsyndrome:prevention and treatment[J].Hepatology, 2001, 34 (6) :1242.
|
[6]ArroyoV, Guevara M, Gines P.Hepatorenal syndromein cirrhosis pathogenesis and treatment[J].Gastroenterology, 2002, 122 (8) :1658-1676.
|
[7]刘金旭, 陈文梅, 肝肾综合征的研究进展[J], 实用肝病杂志, 2008, 12 (6) :426-428.
|
[8]周晓琳, 覃慧敏, 谢迎春, 等.肝硬化腹腔积液并发肝肾综合征的高危因素探讨[J].中国综合临床杂志, 2007, 6 (23) :508-510.
|
[9]刘芳, 何维新, 谢娟, 等, 肝肾综合征诊治现状[J].中华肝脏病杂志, 2003, 11 (10) :638.
|
[10]秦向荣.生长抑素治疗I型肝肾综合征的疗效观察[J].药学与临床研究, 2007, 15 (6) :470-471.
|
[11]Fabrizi F, Dixit V, Martin P.Meta-analysis:terlipressintherapy for the hepatorenal syndrome[J].AlimentPharmacol Ther, 2006, 24 (6) :935-944.
|
[12]陈炎, 陈亚蓓, 陶荣芳.全腹腔穿刺放液对肝硬化门静脉血流动力学的影响[J].中国实用内科杂志, 2004, 24 (8) :473-475.
|
[13]胡哨兵, 杨湛, 唐小平, 等.分子吸附循环系统治疗慢性重症肝炎患者预后的改善[J].中华肝脏病杂志, 2003, 11 (10) :629-630.
|
[14]Paolo Angeli, Carlo merkel.Pathogenesis and ma-nagenment of hepatorenal syndrome in patients withcirrhosis[J].J Hepatology, 2008, 48 (Suppl 1) :S93-S103.
|
[1] | Rong SUN, Li JIANG. Research advances in biomarkers for hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2023, 39(9): 2225-2230. doi: 10.3969/j.issn.1001-5256.2023.09.029 |
[2] | Jiaqi LIANG, Wen LIU. Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 1974-1979. doi: 10.3969/j.issn.1001-5256.2022.09.005 |
[3] | Lihong YANG, Jinhui YANG. Mechanism and treatment of portal-systemic circulatory imbalance in hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2021, 37(12): 2770-2773. doi: 10.3969/j.issn.1001-5256.2021.12.006 |
[4] | LI Yan, LU LunGen. Emphasis on the basic and clinical research on hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2401-2405. doi: 10.3969/j.issn.1001-5256.2020.11.001 |
[5] | SONG JingRu, SUN MingYu. Research advances in integrated traditional Chinese and Western medicine therapy for hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2561-2564. doi: 10.3969/j.issn.1001-5256.2020.11.037 |
[6] | LI XiaoYun, HUA Jing. Treatment of hepatorenal syndrome:Vasoconstriction or vasodilation?[J]. Journal of Clinical Hepatology, 2020, 36(11): 2419-2422. doi: 10.3969/j.issn.1001-5256.2020.11.005 |
[7] | CHEN WenJi, LIANG Wei, ZHOU YongJian. Acute kidney injury and hepatorenal syndrome in end-stage liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2423-2428. doi: 10.3969/j.issn.1001-5256.2020.11.006 |
[8] | LI Yan, LU LunGen, CAI XiaoBo. Advances in the treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2415-2418. doi: 10.3969/j.issn.1001-5256.2020.11.004 |
[9] | LIAO XianHua, YE JunZhao, ZHONG BiHui. Pathogenesis of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2020, 36(11): 2406-2410. doi: 10.3969/j.issn.1001-5256.2020.11.002 |
[10] | Chen LanLan, Han Wen, Liu JingJing, Hu Dan, He WeiWei. Research advances in the biomarkers for the early diagnosis of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2018, 34(11): 2448-2452. doi: 10.3969/j.issn.1001-5256.2018.11.040 |
[11] | Song TingXue, Qi XingShun, Gao Fan, Guo XiaoZhong. Advances in diagnosis and treatment of hepatorenal syndrome type of acute kidney injury in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 572-576. doi: 10.3969/j.issn.1001-5256.2017.03.039 |
[12] | Chen Li, Mei Yong, Yang YiBin, Cao MingYan. Research advances in renal replacement therapy for hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2016, 32(3): 605-608. doi: 10.3969/j.issn.1001-5256.2016.03.046 |
[13] | Gao BaoXiu, He Yong, Li GuiXing, Nie Xin, Luo TongXing, Song HaoLan. Analysis of relationship of chronic severe hepatitis with hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(7): 749-751. |
[14] | Chen ShengPeng, He WeiPing, Li YuFang, Wu JiJun. Clinical analysis of misdiagnosis and missed diagnosis of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(4): 444-445. |
[15] | Wang JiYao. The difficulties in diagnosis and treatment of hepatorenal syndrome-raised by clinical cases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1019-1021. |
[16] | Xu XiaoYuan, Zheng YingYing. Hepatorenal syndrome-vasoconstrictor or vasodilator?[J]. Journal of Clinical Hepatology, 2011, 27(8): 801-803+817. |
[17] | Xie YongPeng, Hou Yue, Zang XiuXian, Chu Zhe. The development of treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2011, 27(5): 558-561. |
[18] | Fu Qiang, Tang TongYu. Advance in research of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2010, 26(5): 557-560. |